Skip to main content

Seramune I.V.

This page contains information on Seramune I.V. for veterinary use.
The information provided typically includes the following:
  • Seramune I.V. Indications
  • Warnings and cautions for Seramune I.V.
  • Direction and dosage information for Seramune I.V.

Seramune I.V.

This treatment applies to the following species:
Company: Sera

equine IgG

dose: administer 250ml intravenously in no less than 30 minutes; repeat as clinical conditions indicate, within first 120 hours of life

● store refrigerated at 2 - 8° C/35 - 46° F; do not freeze

● once opened, use entire contents as directed above

to facilitate use, the following measures are suggested:

● dilute product into 1 - 2 liters of lactated ringers

● warm solution to body temperature

● premedicate with an anti-inflammatory and / or sedative in accordance with current practice standards in neonatal foals

● administer slowly for first 3 - 5 minutes

bottle contains one dose of 250ml

for use by or under the direction of a veterinarian

Seramune I.V. Indications

for the treatment of failure of passive transfer in neonatal foals

do not mix with other products, except as specified on the label

in case of human exposure, contact a physician

with any serum product, adverse reactions may occur; in case of reactions, stop treatment and administer epinephrine

use of equine serum and plasma products has been associated with hepatitis (Theiler’s Disease)

VLN/PCN 328/3607.00


sera, inc., po box 15866, shawnee mission, kansas 66285-5866 usa


CPN: 1498000.2

P.O. BOX 15866, SHAWNEE MISSION, KS, 66285-5866
Telephone:   913-541-1307
Toll-Free:   800-552-3984
Fax:   913-541-1712
Every effort has been made to ensure the accuracy of the Seramune I.V. information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the US product label or package insert.

Copyright © 2022 Animalytix LLC. Updated: 2021-11-29